SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-021577
Filing Date
2022-11-03
Accepted
2022-11-03 08:29:46
Documents
14
Period of Report
2022-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cinc-20221103.htm   iXBRL 8-K 56848
2 EX-99.1 cinc-ex99_1.htm EX-99.1 141467
3 GRAPHIC img73281002_0.jpg GRAPHIC 3606
  Complete submission text file 0000950170-22-021577.txt   335198

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cinc-20221103.xsd EX-101.SCH 2451
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cinc-20221103_pre.xml EX-101.PRE 10218
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cinc-20221103_lab.xml EX-101.LAB 13904
8 EXTRACTED XBRL INSTANCE DOCUMENT cinc-20221103_htm.xml XML 4879
Mailing Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451
Business Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451 8445311834
CinCor Pharma, Inc. (Filer) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41201 | Film No.: 221356385
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences